Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Vargas Robles, Hilda ^a   Rios, Amelia ^b   Arellano Mendoza, Monica ^a   Escalante, Bruno A ^b   Schnoor, Michael ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIOXIDANTS; BLOOD PRESSURE; BODY FLUIDS; MAMMALS; OXIDATIVE STRESS; UNSATURATED FATTY ACIDS;

BENEFICIAL EFFECTS; CARDIO-VASCULAR RISK FACTORS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; HIGH-FAT DIET; NATURAL ANTIOXIDANTS; SERUM TRIGLYCERIDE; SYNTHETIC ANTIOXIDANTS;

NUTRITION;

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; ICOSAPENTAENOIC ACID; TRIACYLGLYCEROL; ANTIOXIDANT; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; OMEGA 3 FATTY ACID; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; LIPID DIET; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

MUS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDES; TRIGLYCERIDES;

EID: 84928474053     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/467471     Document Type: Article

References (38)

1. M. A. van Baak, "Nutrition as a link between obesity and cardiovascular disease: how can we stop the obesity epidemic?" Thrombosis and Haemostasis, vol. 110, no. 4, pp. 689-696, 2013.
2. M. A. Pereira, T. E. Kottke,C. Jordan, P. J. OConnor,N. P. Pronk, and R. Carreon, "Preventing and managing cardiometabolic risk: the logic for intervention," International Journal of Environmental Research and PublicHealth, vol. 6, no. 10, pp. 2568-2584, 2009.
3. M. Kratz, T. Baars, and S. Guyenet, "The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease," European Journal of Nutrition, vol. 52, no. 1, pp. 1-24, 2013.
4. E. Hopps, D. Noto, G. Caimi, and M. R. Averna, "A novel component of the metabolic syndrome: the oxidative stress," Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 1, pp. 72-77, 2010.
5. O. Galili, D. Versari, K. J. Sattler et al. , "Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress," American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 2, pp. H904-H911, 2007.
6. I. Abete, E. Goyenechea, M. A. Zulet, and J. A. Martinez, "Obesity and metabolic syndrome: potential benefit from specific nutritional components," Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, supplement 2, pp. B1-B15, 2011.
7. A. B. Crujeiras, M. D. Parra, M. C. Rodriguez, B. E. Martinez de Morentin, and J. A. Martinez, "Arole for fruit content in energyrestricted diets in improving antioxidant status in obese women during weight loss," Nutrition, vol. 22, no. 6, pp. 593-599, 2006.
8. E. Kesse-Guyot, N. Ahluwalia, C. Lassale, S. Hercberg, L. Fezeu, and D. Lairon, "Adherence toMediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study," Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, no. 7, pp. 677-683, 2013.
9. O. Ilkun and S. Boudina, "Cardiac dysfunction and oxidative stress in the metabolic syndrome: An update on antioxidant therapies," Current Pharmaceutical Design, vol. 19, no. 27, pp. 4806-4817, 2013.
10. S. Devaraj, R. Tang, B. Adams-Huet et al. , "Effect of highdose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease,"The American Journal of Clinical Nutrition, vol. 86, no. 5, pp. 1392-1398, 2007.
11. J. H. Y. Wu, N. C. Ward, A. P. Indrawan et al. , "Effects of α-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes," Clinical Chemistry, vol. 53, no. 3, pp. 511-519, 2007.
12. M. Wallert, L. Schmolz, F. Galli,M. Birringer, and S. Lorkowski, "Regulatory metabolites of vitamin E and their putative relevance for atherogenesis," Redox Biology, vol. 2, pp. 495-503, 2014.
13. M. Meydani, "Vitamin Emodulation of cardiovascular disease," Annals of the New York Academy of Sciences, vol. 1031, pp. 271-279, 2004.
14. G. Cao, R. M. Russell, N. Lischner, and R. L. Prior, "Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women," Journal of Nutrition, vol. 128, no. 12, pp. 2383-2390, 1998.
15. M. G. Arellano-Mendoza, H. Vargas-Robles, L. del Valle-Mondragon, A. Rios, and B. Escalante, "Prevention of renal injury and endothelial dysfunction by chronic L-arginine and antioxidant treatment," Renal Failure, vol. 33, no. 1, pp. 47-53, 2011.
16. A. M. Gamez-Mendez, H. Vargas-Robles, M. Arellano-Mendoza, E. Cruz-Laguna, A. Rios, and B. Escalante, "Early stage of obesity potentiates nitric oxide reduction during the development of renal failure," Journal of Nephrology, vol. 27, no. 3, pp. 281-287, 2014.
17. M. G. A. Mendoza, C. Castillo-Henkel, R. Medina-Santillan et al. , "Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-arginine and antioxidants," Nephrology, vol. 13, no. 3, pp. 218-227, 2008.
18. M. A. Alam, K. Kauter, K. Withers, C. Sernia, and L. Brown, "Chronic l-arginine treatment improves metabolic, cardiovascular and liver complications in diet-induced obesity in rats," Food and Function, vol. 4, no. 1, pp. 83-91, 2013.
19. B. Harwell, "Biochemistry of oxidative stress," Biochemical Society Transactions, vol. 35, no. 5, pp. 1147-1150, 2007.
20. N. Demircan, A. Gurel, F. Armutcu, M. Unalacak, E. Aktunc, and H. Atmaca, "The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome," Medical Science Monitor, vol. 14, no. 2, pp. CR97-CR101, 2008.
21. J. E. Barbato, B. S. Zuckerbraun, M. Overhaus, K. G. Raman, and E. Tzeng, "Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 1, pp. H228-H236, 2005.
22. N. Abdilla, M. C. Tormo, M. J. Fabia, F. J. Chaves, G. Saez, and J. Redon, "Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension," Journal ofHuman Hypertension, vol. 21,no. 1, pp. 68-75, 2007.
23. V. O. Palmieri, I. Grattagliano, P. Portincasa, and G. Palasciano, "Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome," Journal of Nutrition, vol. 136, no. 12, pp. 3022-3026, 2006.
24. Q. Wang, Y. Sun,A. Ma, Y. Li, X. Han, and H. Liang, "Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome," International Journal for Vitamin and Nutrition Research, vol. 80, no. 3, pp. 178-187, 2010.
25. J. Montonen, P. Knekt, R. Jarvinen, and A. Reunanen, "Dietary antioxidant intake and risk of type 2 diabetes," Diabetes Care, vol. 27, no. 2, pp. 362-366, 2004.
26. J. A. Beckman, A. B. Goldfine, M. B. Gordon, and M. A. Creager, "Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans," Circulation, vol. 103, no. 12, pp. 1618-1623, 2001.
27. N. G. Stephens, A. Parsons, P. M. Schofield et al. , "Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)," The Lancet, vol. 347, no. 9004, pp. 781-786, 1996.
28. C. J. Lavie and J. N. Milani, "Do antioxidant vitamins ameliorate the beneficial effects of exercise training on insulin sensitivity?" Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 31, no. 4, pp. 211-216, 2011.
29. M. Meydani, P. Kwan,M. Band et al. , "Long-termvitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet," Atherosclerosis, vol. 233, no. 1, pp. 196-205, 2014.
30. M. S. Farvid, M. Jalali, F. Siassi, and M. Hosseini, "Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes," Diabetes Care, vol. 28, no. 10, pp. 2458-2464, 2005.
31. D. N. Granger, S. F. Rodrigues, A. Yildirim, and E. Y. Senchenkova, "Microvascular responses to cardiovascular risk factors," Microcirculation, vol. 17, no. 3, pp. 192-205, 2010.
32. J. Lorin, M. Zeller, J.-C. Guilland, Y. Cottin, C. Vergely, and L. Rochette, "Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects," Molecular Nutrition and Food Research, vol. 58, no. 1, pp. 101-116, 2014.
33. P. N. Chander,O. Gealekman, S. V. Brodsky et al. , "Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen," Journal of the American Society of Nephrology, vol. 15, no. 9, pp. 2391-2403, 2004.
34. S. Lorente-Cebrian, A. G. V. Costa, S. Navas-Carretero, M. Zabala, J. A. Martinez, and M. J. Moreno-Aliaga, "Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a reviewof the evidence," Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 633-651, 2013.
35. M. Iantorno, U. Campia, N. Di Daniele et al. , "Obesity, inflammation and endothelial dysfunction," Journal of Biological Regulators and Homeostatic Agents, vol. 28, no. 2, pp. 169-176, 2014.
36. G. Singer and D. N. Granger, "Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance,"Microcirculation, vol. 14,no. 4-5, pp. 375-387, 2007.
37. J. F. Ndisang, "Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity," Mediators of Inflammation, vol. 2010,Article ID 359732, 18 pages, 2010.
38. A. J. Szalai,M. A. McCrory, D. Xing et al. , "InhibitingC-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models," Mediators of Inflammation, vol. 2014, Article ID353614, 9 pages, 2014.